Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side ...

One injection a week instead of one every day. Danish drugmaker Novo Nordisk has launched Awiqli, or insulin icodec, in India-the world's first once-weekly bas ...

The injection replaces the need for a daily basal insulin injection with a once-a-week dose. This reduces the annual number ...

By Rishika Sadam July 9 (Reuters) - Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in ...

A major breakthrough for diabetes care has arrived in India. Novo Nordisk has launched Awiqli, the world's first once-weekly ...

Indian pharma majors Sun Pharma, Dr Reddy's and Glenmark on Saturday announced the launch of their generic versions of ...

Lupin will gain semi-exclusive co-marketing rights for Zydus’ semaglutide injection in India under Semanext and Livarise, while Zydus retains its brands Semaglyn, Mashema and Alterme. Managing ...